drug

tenapanor

1 story · latest Aug 6, 2026

Status: FDA approved Sep 2019 · NDA211801, NDA213931
Brands: Ibsrela, Xphozah, Xphozah 10 Mg, Xphozah 20 Mg, Xphozah 30 Mg
Trials: 2 registered trials in coverage

Relationships

Developed by Ardelyx

Also known as

tenapanor hydrochloride

Timeline

Ardelyx revises IBSRELA guidance, pulls XPHOZAH long-term outlook amid payor hurdles

Aug 6Quarterly updateArdelyx tenapanor

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.